In vivo inhibition of nitric oxide synthase by bisisothiouronium and bisguanidinium salts.
The ability of two S,S'-(alkane-1,omega-diyl) bisisothiouronium dibromides, three N,N'-(alkane-1, omega-diyl) bis guanidinium dinitrates and N,N'-bis (3-guanidinopropyl)piperazine dinitrate to inhibit constitutive (i.e. endothelial and neuronal forms) and inducible forms of nitric oxide synthases has been evaluated in vivo. These compounds, synthesized by two of us (J. C. L. and C. S.), have been tested in vivo; they were administered simultaneously with an irritant (carrageenan lambda) into the pleural cavity. The amount of nitrites collected 0.5 and 7 hours after this injection can be considered as an indicator of nitric oxide (NO) production. According to previous data, the first harvesting time can be related to activation of constitutive NO synthases and the second to activation of inducible NO synthases. These substances significantly inhibited nitrite production as did 2-methyl-2-thiopseudourea sulphate, previously described as a potent inhibitor of NO synthases and considered as the reference compound. The inhibiting effect varied according to the chemical structure of the compounds. Results were significantly different from controls at 0.5 h only with the S,S'-(octane-1,8-diyl) bisisothiouronium dibromide and the S,S'-(nonane-1,9-diyl) bisisothiouronium dibromide at the highest concentration, N,N'-(heptane-1,7-diyl) bisguanidinium dinitrate and N,N'-bis (3-guanidinopropyl)piperazine dinitrate. At 7 h, all the results were significantly different from controls, with a major effect observed with N,N'-(heptane-1,7-diyl) bisguanidinium dinitrate. The most active substances exerted similar effects to the reference substance.
Roch-Arveiller
M
M
CNRS URA 1534, Laboratoire de Pharmacologie, Hôpital Cochin, Paris, France.
Regnault
C
C
Giroud
J P
JP
Morgant
G
G
Lancelot
J C
JC
Saturnino
C
C
Perrine
D
D
Nguyen Huy
D
D
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D002351:Carrageenan / Q000008:administration & dosage; D004790:Enzyme Induction / Q000187:drug effects; D006146:Guanidines / Q000737:chemistry / Q000494:pharmacology*; D007550:Isothiuronium / Q000031:analogs & derivatives* / Q000737:chemistry; D008297:Male; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D010994:Pleura / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013329:Structure-Activity Relationship; D013890:Thiourea / Q000031:analogs & derivatives
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006146:Guanidines; D007550:Isothiuronium; D009569:Nitric Oxide; D002351:Carrageenan; D019001:Nitric Oxide Synthase; D013890:Thiourea